Oscar Health, Inc.

As of June 30, 2026, Oscar Health, Inc. Class A carries a market capitalization of 7.55B, placing it among publicly traded companies globally. Its enterprise value stands at 445.72M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Oscar Health, Inc. Class A's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Oscar Health, Inc. Class A has 308.63M shares outstanding.

As of June 30, 2026, Oscar Health, Inc. Class A trades at a trailing price-to-earnings ratio of 14.51. The price-to-sales ratio is 0.52, and the price-to-book ratio stands at 4.21.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Oscar Health, Inc. Class A trades at an EV/FCF ratio of 0.12, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 445.72M versus a market cap of 7.55B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Oscar Health, Inc. Class A posted a return on equity (ROE) of 34.31, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 6.25, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 28.64, useful for judging operating efficiency across full business cycles. The company generates approximately 5.76M in revenue per employee across its workforce of 2,328.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Oscar Health, Inc. Class A recorded 34.03M in income tax expense. That works out to an effective tax rate of 6.59, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 516.26M, leaving 482.07M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

These figures are as of the close on October 6, 2026. The 50-day moving average sits at 26.76, while the 200-day moving average is 19.31.

Over the twelve months ended June 30, 2026, Oscar Health, Inc. Class A generated 13.41B in revenue and converted that into 482.07M in net income, yielding earnings per share of 1.60.

As of June 30, 2026, Oscar Health, Inc. Class A holds 7.49B in cash and equivalents against 377.80M in total debt, resulting in a net debt position of -3.19B.

Oscar Health, Inc. Class A produced 3.87B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -33.81M in capital expenditures, free cash flow totaled 3.83B - equivalent to 13.42 per share.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 51.97, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -4.43, meaning Oscar Health, Inc. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.